Home › Blood Disorders
Blood Disorders clinical trials recruiting in the U.S.
36 studies for Blood Disorders are recruiting participants at sites across the United States.
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. Find out about the types, causes, and treatments.
Cities with the most studies
- Houston, TX11 studies
- Atlanta, GA11 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- New York City, NY9 studies
- The Bronx, NY8 studies
- Durham, NC7 studies
- Nashville, TN7 studies
- Mountain View, CA7 studies
- San Diego, CA6 studies
- Seattle, WA6 studies
- Indianapolis, IN5 studies
- Portland, OR5 studies
- Washington, DC5 studies
- Greenville, NC5 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Milwaukee, WI4 studies
- Tampa, FL4 studies
- Philadelphia, PA4 studies
- Cleveland, OH4 studies
- Baldwin Park, CA4 studies
- Birmingham, AL4 studies
- St. Louis, MO3 studies
- Augusta, GA3 studies
- Phoenix, AZ3 studies
- Orange, CA3 studies
- Buffalo, NY3 studies
- Clifton, NJ3 studies
- Sacramento, CA3 studies
- Cedar Rapids, IA3 studies
- Baltimore, MD3 studies
- Kansas City, MO3 studies
- San Francisco, CA3 studies
- Norfolk, VA3 studies
- Louisville, KY3 studies
By state
- Alabama5 studies
- Arizona3 studies
- Arkansas3 studies
- California19 studies
- District of Columbia4 studies
- Florida10 studies
- Georgia13 studies
- Indiana5 studies
- Iowa3 studies
- Kentucky4 studies
- Maryland5 studies
- Massachusetts10 studies
- Minnesota4 studies
- Missouri5 studies
- New Jersey5 studies
- New York14 studies
- North Carolina11 studies
- Ohio7 studies
- Oregon5 studies
- Pennsylvania4 studies
- Tennessee7 studies
- Texas12 studies
- Virginia6 studies
- Washington7 studies
- Wisconsin5 studies
Recently updated studies
A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia
RecruitingPhase 3
Ages 12 to 70 · All sexes · Updated Nov 13, 2026 · NCT07935356A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Nov 10, 2026 · NCT06439082Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07601425A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07712562Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults
RecruitingPhase 1
3 Months – 25 Years · All sexes · Updated Oct 29, 2026 · NCT04806347HEME Home Transfusion Program
Recruiting
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06487247A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 22, 2026 · NCT07059000Therapeutic RSK1 Targeting in Myeloid Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07379125Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05423691Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 14, 2026 · NCT06828796A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT04256317Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969Treatment of Hemophilia A Patients With FVIII Inhibitors
RecruitingObservational study
All ages · Men · Updated Sep 23, 2026 · NCT04023019(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07075185ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05254743Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Recruiting
Up to age 55 · All sexes · Updated Jul 6, 2026 · NCT01666080ATHNdataset Registry
RecruitingObservational study
All ages · All sexes · Updated Apr 21, 2026 · NCT06820515Diamond Blackfan Anemia Registry (DBAR)
RecruitingObservational study
All ages · All sexes · Updated Apr 16, 2026 · NCT00106015Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
RecruitingObservational studyHealthy volunteers welcome
Ages 19 and older · All sexes · Updated Apr 2, 2026 · NCT03207854From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.